Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
insulin human · 1 trial · 2 indications
| Name | Type | Description |
|---|---|---|
| insulin human | DRUG | - |
| insulin lispro | DRUG | - |
| insulin aspart | DRUG | - |
Inclusion Criteria: * Pediatric patients with Type 1 diabetes for at least one year * HbA1c less than 12% * Willing to administer at least 3 injections per day * Willing to perform self monitored blood glucose (SMBG) at least 4 times per day, includes subject and/or parent/guardian, as necessary
| Company | Ticker | Trials | Lead Phase | Drugs |
|---|---|---|---|---|
| FibroBiologics, Inc. | FBLG | 1 | PHASE1 | Undisclosed |
| MiMedx Group, Inc. | MDXG | 2 | N/A | Undisclosed |
| Integra LifeSciences Holdings Corporation | IART | 1 | N/A | Undisclosed |
| Organogenesis Holdings, Inc. Class A | ORGO | 1 | N/A | Undisclosed |
| Healthcare Services Group, Inc. | HCSG | 1 | N/A | Undisclosed |